Should we screen and decolonise contacts of patients with Panton Valentine leukocidin associated Staphylococcus aureus infection?

BMJ (Online)

Volumn 343, Issue 7823, 2011, Pages

  Shallcross, L J ^a   Mbeledogu, C N ^b   Hayward, A C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SPRINGFIELD UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; PANTON VALENTINE LEUKOCIDIN; PLACEBO; PSEUDOMONIC ACID; TRICLOSAN; ANTIINFECTIVE AGENT; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN;

ARTICLE; BACTERIAL DECOLONIZATION; CLINICAL EVALUATION; CLINICAL RESEARCH; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; FOLLOW UP; HIGH RISK POPULATION; HOUSEHOLD; HUMAN; INFECTION PREVENTION; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PERSONAL HYGIENE; PRIORITY JOURNAL; RECURRENT INFECTION; RISK ASSESSMENT; RISK REDUCTION; SCREENING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TISSUE SECTION; TREATMENT DURATION; CHEMISTRY; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; HYGIENE; PRACTICE GUIDELINE; RECURRENT DISEASE;

ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; EARLY DIAGNOSIS; EVIDENCE-BASED MEDICINE; EXOTOXINS; HUMANS; HYGIENE; LEUKOCIDINS; PRACTICE GUIDELINES AS TOPIC; RECURRENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 80052995192     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d5479     Document Type: Article

References (9)

1. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA, and participants in the CDC-convened experts' meeting on management of MRSA in the community. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006. www.cdc.gov/ncidod/dhqp/pdf/ar/CAMRSA-ExpMtgStrategies.pdf.
2. Health Protection Agency. Guidance on the diagnosis and management of PVL-associated Staphylococcus aureus infections (PVL-SA) in England. 2008. www.hpa.org.uk/webc/HPAwebfile/HPAweb-C/1218699411960.
3. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666-74.
4. Van Rijen M, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008;4:CD006216.
5. Shallcross LJ, Williams K, Hopkins S, Aldridge RW, Johnson AM, Hayward AC. Panton-Valentine leukocidin associated staphylococcal disease: a cross-sectional study at a London hospital, England. Clin Microbiol Infect 2010;16:1644-8.
6. Del Giudice P, Blanc V, De Rougemont A, Bes M, Lina G, Hubiche T, et al. Primary skin abscesses are mainly caused by Panton-Valentine leukocidin-positive Staphylococcus aureus strains. Dermatology 2009;219:299-302.
7. Jappe U, Heuck D, Strommenger B, Wendt C, Werner G, Altmann D, et al. Staphylococcus aureus in dermatology outpatients with special emphasis on community-associated methicillin-resistant strains. J Invest Dermatol 2008;128:2655-64.
8. Health Protection Agency Local and Regional Services. Management of PVL-Staphylococcus aureus recommendations for practice. www.hpa.org.uk/web/ HPAwebFile/HPAweb-C/1267551719486. 2010.
9. Laupland KB, Church DL, Mucenski M, Sutherland LR, Davies HD. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 2003;187:1452-9. (Pubitemid 36549691)